Home › Type 1 Diabetes › NCT06297980
Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes
Who can join
Ages 18 to 45 · Women
Full eligibility criteria
Inclusion Criteria: * Women 18-45 who have had type 1 diabetes for at least 12 months * Premenopausal with either menstrual cycles or currently using oral contraceptives Exclusion Criteria: * Women who are postmenopausal, pregnant, trying to become pregnant, or have had a hysterectomy
About the study
The objectives of this study are to examine how sex hormones (use of hormonal birth control, menstrual cycle phase) impact glycemic control among women with type 1 diabetes (T1D), and to test adjustments to insulin dosing and food intake to ameliorate cycle-related glycemic variability. A secondary aim is to examine how the menstrual cycle and use of hormonal birth control impact patient-reported outcomes and glycemic responses to physical activity.
What is being tested
- Personalized modifications to treatment to address menstrual cycle effects on glycemia (other)
Sponsor: University of Colorado, Denver · Participants: 150 · Started: Mar 24, 2024
Contact the study team
- JANET K SNELL-BERGEON, PhD, MPH · Phone: 3037246762
- Catherine Chartier-Logan, MPH · Phone: 3037247505
Official record on ClinicalTrials.gov — NCT06297980
Locations in the U.S.
| Colorado | University of Colorado, Aurora |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.